Clinical Biostatistics

An in-house biostatistics team offers deep familiarity with your organization’s processes and therapeutic focus, but building and maintaining that team requires significant investment in hiring, training, and infrastructure. A biostatistics CRO like Ephicacy brings a broader bench that most sponsors cannot cost-effectively replicate internally. Outsourcing makes sense particularly when your program is scaling faster than your internal capacity allows, when you need specialized expertise for a complex study design, or when you want to move faster without absorbing fixed overhead. Many sponsors use a hybrid approach, retaining strategic oversight in-house while leaning on a CRO partner for execution and surge capacity. 

Engaging a biostatistics partner at the study design stage, before protocols are finalized, unlocks significantly more value than bringing one in purely for analysis. Early involvement means: 

• Stronger study design: Biostatisticians can flag feasibility risks, recommend appropriate statistical models, and ensure the design will support your intended regulatory claim 
• Better endpoint selection: Choosing the right primary and secondary endpoints, and defining them precisely, has downstream consequences for analysis, sample size, and regulatory acceptance 
• Accurate sample size calculations: These need to reflect realistic assumptions, and getting them wrong early is costly to correct later 
• SAP alignment: An early engaged biostatistician can ensure the Statistical Analysis Plan is built in parallel with the protocol, not retrofitted after the fact 

A biostatistician’s involvement in protocol development goes well beyond number crunching. During protocol development, they provide critical input on study design, help define inclusion and exclusion criteria that support clean analysis, and ensure the statistical methodology is sound and fit for regulatory scrutiny. On endpoint selection, their role is to assess whether proposed endpoints are measurable, appropriate for the study population, and statistically powered to detect a meaningful clinical effect. They also advise on the hierarchy of endpoints to manage multiplicity concerns and align with regulatory expectations. In short, a biostatistician helps ensure that the scientific ambition of a trial is matched by a design that can actually deliver defensible results. 

Ephicacy’s delivery model is built around using the right resources in the right locations to maximize value: 

• Cost-effective resourcing: India-based operations can offer lower cost structures 
• No compromise on quality: Ephicacy’s India teams operate under the same SOPs, quality frameworks, and regulatory standards as the broader global organization 
• 24/7 coverage: The geographic spread of Ephicacy’s teams enables round-the-clock productivity, meaning timelines don’t stall between business days 
• Experienced professionals: Ephicacy’s 360+ biostatisticians and programmers average 5+ years of experience, ensuring that cost efficiency is delivered by tenured professionals, not junior resources 
• Flexible scaling: Our India presence makes it easier to scale resources up or down in response to trial demands without the lag of recruiting or the risk of over hiring